Bio-Rad Laboratories Stock (NYSE:BIO), Quotes and News Summary

Q: What sector and industry does Bio-Rad Laboratories (BIO) operate in?

Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

Bio-Rad Laboratories Stock (NYSE: BIO) stock price, news, charts, stock research, profile.

Open	$275.830
Close	$281.020
Volume / Avg.	373.365K / 205.350K
Day Range	268.916 - 286.650
52 Wk Range	261.590 - 489.355
Market Cap	$8.014B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	25
Short Interest	3.17%
Days to Cover	3.2

Recent News

96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?

480 out of 500 S&P 500 companies are trading below analysts' price targets, indicating potential profit opportunities. April has been bleak for the market, but some undervalued stocks may be worth buying. Top 5 stocks with biggest gap between price and target: CCL, BIO, WBD, CZR, CCO.

Piero Cingari

Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday?

Wall Street takes pause after stronger-than-expected producer inflation report, potentially delaying Fed rate cuts and impacting major indices and stocks.

Piero Cingari

Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Bio-Rad Laboratories Inc.

Sector

Health Care

Industry

Life Sciences Tools & Services

Bio-Rad Laboratories Inc manufactures, and markets products and solutions for the clinical diagnosti...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Bio-Rad Laboratories (BIO) stock?

You can purchase shares of Bio-Rad Laboratories (NYSE: BIO) through any online brokerage.

View our list of the best stock brokerages.

Who are Bio-Rad Laboratories's (BIO) competitors?

Other companies in Bio-Rad Laboratories’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Waters (NYSE:WAT) and Danaher (NYSE:DHR).

What is the target price for Bio-Rad Laboratories (BIO) stock?

The latest price target for Bio-Rad Laboratories (NYSE: BIO) was reported by Citigroup on Wednesday, April 3, 2024. The analyst firm set a price target for 365.00 expecting BIO to rise to within 12 months (a possible 29.88% upside). 11 analyst firms have reported ratings in the last year.

Current Stock Price for Bio-Rad Laboratories (BIO)?

The stock price for Bio-Rad Laboratories (NYSE: BIO) is $281.02 last updated April 18, 2024 at 4:00 PM EDT.

Does Bio-Rad Laboratories (BIO) pay a dividend?

A quarterly cash dividend of $0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.

When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?

Bio-Rad Laboratories’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Bio-Rad Laboratories (BIO) going to split?

There is no upcoming split for Bio-Rad Laboratories.

What sector and industry does Bio-Rad Laboratories (BIO) operate in?

Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-